Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Plasma glucosylceramides and cardiovascular risk in incident hemodialysis patients.

Mitsnefes MM, Fitzpatrick J, Sozio SM, Jaar BG, Estrella MM, Monroy-Trujillo JM, Zhang W, Setchell K, Parekh RS.

J Clin Lipidol. 2018 Nov - Dec;12(6):1513-1522.e4. doi: 10.1016/j.jacl.2018.07.011. Epub 2018 Jul 30.

PMID:
30143433
2.

Association of Abdominal Adiposity with Cardiovascular Mortality in Incident Hemodialysis.

Fitzpatrick J, Sozio SM, Jaar BG, McAdams-DeMarco MA, Estrella MM, Tereshchenko LG, Monroy-Trujillo JM, Parekh RS.

Am J Nephrol. 2018;48(6):406-414. doi: 10.1159/000494281. Epub 2018 Nov 14.

PMID:
30428465
3.

Increased risk of fatal infections in women starting peritoneal dialysis.

Ros S, Remón C, Qureshi AR, Quiros P, Lindholm B, Carrero JJ.

Perit Dial Int. 2013 Sep-Oct;33(5):487-94. doi: 10.3747/pdi.2012.00243. Epub 2013 Oct 1.

4.
5.

Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.

Shafi T, Zager PG, Sozio SM, Grams ME, Jaar BG, Christenson RH, Boulware LE, Parekh RS, Powe NR, Coresh J.

Am J Kidney Dis. 2014 Sep;64(3):443-51. doi: 10.1053/j.ajkd.2014.03.015. Epub 2014 Apr 29.

7.

Association of Plasma Thrombospondin-1 Level with Cardiovascular Disease and Mortality in Hemodialysis Patients.

Huang CL, Jong YS, Wu YW, Wang WJ, Hsieh AR, Chao CL, Chen WJ, Yang WS.

Acta Cardiol Sin. 2015 Mar;31(2):113-9.

8.

Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Whitlock EP, Williams SB, Burda BU, Feightner A, Beil T.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep.

9.

Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.

Genovesi S, Vincenti A, Rossi E, Pogliani D, Acquistapace I, Stella A, Valsecchi MG.

Am J Kidney Dis. 2008 Feb;51(2):255-62. doi: 10.1053/j.ajkd.2007.10.034.

PMID:
18215703
10.

Prognosis of individuals with asymptomatic left ventricular systolic dysfunction in the multi-ethnic study of atherosclerosis (MESA).

Yeboah J, Rodriguez CJ, Stacey B, Lima JA, Liu S, Carr JJ, Hundley WG, Herrington DM.

Circulation. 2012 Dec 4;126(23):2713-9. doi: 10.1161/CIRCULATIONAHA.112.112201. Epub 2012 Nov 2.

11.

Association of Fitness in Young Adulthood With Survival and Cardiovascular Risk: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Shah RV, Murthy VL, Colangelo LA, Reis J, Venkatesh BA, Sharma R, Abbasi SA, Goff DC Jr, Carr JJ, Rana JS, Terry JG, Bouchard C, Sarzynski MA, Eisman A, Neilan T, Das S, Jerosch-Herold M, Lewis CE, Carnethon M, Lewis GD, Lima JA.

JAMA Intern Med. 2016 Jan;176(1):87-95. doi: 10.1001/jamainternmed.2015.6309.

12.

Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group.

Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF, Robbins J.

J Am Geriatr Soc. 2000 Feb;48(2):115-23.

PMID:
10682939
13.

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.

Bostom AG, Shemin D, Verhoef P, Nadeau MR, Jacques PF, Selhub J, Dworkin L, Rosenberg IH.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2554-8.

PMID:
9409227
14.

Left ventricular ejection fraction is associated with prevalent and incident cardiovascular disease in patients with intermittent claudication - results from the CAVASIC Study.

Rantner B, Pohlhammer J, Stadler M, Peric S, Hammerer-Lercher A, Klein-Weigel P, Fraedrich G, Kronenberg F, Kollerits B.

Atherosclerosis. 2015 Apr;239(2):428-35. doi: 10.1016/j.atherosclerosis.2014.12.060. Epub 2015 Jan 17.

PMID:
25682043
15.

Phenotypic and genotypic risk factors for cardiovascular events in an incident dialysis cohort.

Pernod G, Bosson JL, Golshayan D, Barro C, Forneris G, Martina G, Bonfant G, Hurot JM, Turc-Baron C, Jouet C, Theytaz J, Jeantet A, Wauters JP, Cordonnier D; Diamant Alpin Collaborative Dialysis Study Group.

Kidney Int. 2006 Apr;69(8):1424-30.

16.

Superior mesenteric artery calcification is associated with cardiovascular risk factors, systemic calcified atherosclerosis, and increased mortality.

Lin TC, Wright CM, Criqui MH, Allison MA.

J Vasc Surg. 2018 May;67(5):1484-1490. doi: 10.1016/j.jvs.2017.08.081. Epub 2017 Nov 2.

PMID:
29103930
17.

Electrophysiologic Substrate and Risk of Mortality in Incident Hemodialysis.

Tereshchenko LG, Kim ED, Oehler A, Meoni LA, Ghafoori E, Rami T, Maly M, Kabir M, Hawkins L, Tomaselli GF, Lima JA, Jaar BG, Sozio SM, Estrella M, Kao WH, Parekh RS.

J Am Soc Nephrol. 2016 Nov;27(11):3413-3420. Epub 2016 Apr 29.

19.

Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.

von Scholten BJ, Reinhard H, Hansen TW, Oellgaard J, Parving HH, Jacobsen PK, Rossing P.

Diabetologia. 2016 Jul;59(7):1549-1557. doi: 10.1007/s00125-016-3937-0. Epub 2016 Mar 31.

PMID:
27033561
20.

Different impact of hemodialysis vintage on cause-specific mortality in long-term hemodialysis patients.

Sumida K, Yamagata K, Iseki K, Tsubakihara Y.

Nephrol Dial Transplant. 2016 Feb;31(2):298-305. doi: 10.1093/ndt/gfv402. Epub 2015 Dec 13.

PMID:
26666499

Supplemental Content

Support Center